SP1 and cancer: Several pathways have been described for enhanced Sp degradation in cancer cell lines and these include activation of proteasomes, caspases and ROS [17]–[20], [22]–[26] and also a pathway which involves nuclear export of Sp1 followed by proteolytic degradation in the cytosol [30].